532
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study

, , , , , , & show all

References

  • Vestbo J HS, Agusti AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187:347–365.
  • Barnes PJ CB. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165–1185.
  • GM. R. Role of insulin resistance in human disease. Diabetes 1988; 37:1595–1607.
  • Bressler P BS, Matsuda M, et al. Insulin resistance and coronary artery disease. Diabetologia 1996; 39:1345–1350.
  • Rasouli N KP. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93:64–73.
  • Yang D LZ, Yang H, et al. Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 2013; 17:33–38.
  • Sharma SK AS, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011; 365:2277–2286.
  • W. W. Impact of home mechanical ventilation on health-related quality of life. Eur Respir J 2008; 32:1328–1336.
  • Tsolaki V PC, Karetsi E, et al. One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life. Respir Med 2008; 102:904–911.
  • Celli BR MW. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
  • Windisch W KS, Dreher M, et al. Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of Pa(CO2). Chest 2005; 128:657–662.
  • Standardization of Spirometry UATS. Am J Respir Crit Care Med 1995; 152:1107–1136.
  • Mahler DA WC. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93:580–586.
  • MW. J. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep Breath 1991; 14:540–545.
  • Tsara V SE, Amfilochiou A, et al. Greek version of the Epworth Sleepiness Scale. Sleep Breath 2004; 8:91–95.
  • Watz H WB, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136:1039–1046.
  • Dandona P AA, Chaudhuri A, et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111:1448–1454.
  • Weyer C FT, Tanaka S, et al. Hypoadiponectinmia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinmia. J Clin Endocrinol Metab 2001; 86:1930–1935.
  • Tomoda K YM, Itoh T, et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 2007; 132:135–140.
  • Kirdar S SM, Ceylan E, et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest 2009; 69:219–224.
  • Krommidas G KK, Papatheodorou G, Koutsokera A, Gourgoulianis KI, Roussos C, Koulouris NG, Loukides S. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Respir Med 2010; 104:40–46.
  • van den Borst B GH, Wesseling G, et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr 2011; 94:1504–1512.
  • Wannamethee SG LG, Rumley A, et al. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007; 30:1200–1205.
  • Borel JC R-LP, Tamisier R, et al. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One 2009 Aug 24; 4:6733.
  • Steffes MW GM, Lee DH, Schreiner PJ, Jacobs DR Jr. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring) 2006; 14:319–326.
  • Steffes MW GM, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR Jr. Serum adiponectin in young adults–interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004; 14:492–498.
  • Cnop M HP, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46:459–469.
  • Sood A CX, Qualls C, Beckett WS, Gross MD, Steffes MW, Smith LJ, Jacobs DR J. Association between asthma and serum adiponectin concentration in women. Thorax 2008; 63:877–882.
  • Thyagarajan B JDJ, Apostol GG, Smith LJ, Jensen RL, Crapo RO, Barr RG, Lewis CE, Williams OD. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res. 2008 Apr 4;9:31. doi: 10.1186/1465-9921-9-31
  • Walter RE BA, Givelber RJ, O'Connor GT, Gottlieb DJ. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003; 167:911–916.
  • Summer R LF, Ouchi N, Takemura Y, Aprahamian T, Dwyer D, Fitzsimmons K, Suki B, Parameswaran H, Fine A. et al. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1035–1042.
  • Thyagarajan B JDJ, Smith LJ, Kalhan R, Gross MD, Sood A. Serum adiponectin is positively associated with lung function in young adults, independent of obesity: the CARDIA study. Respir Res. 2010 Dec 9;11:176. doi: 10.1186/1465-9921-11-176
  • Fisman EZ TA. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol 2014; 13:103.
  • Ali Assad N SA. Leptin, adiponectin and pulmonary diseases. Biochimie 2012; 94:2180–2189.
  • Davies RJ TR, Crosby J, et al. Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment. J Sleep Res 1994; 3:180–185.
  • Brooks B CP, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79:1681–1685.
  • Trayhurn P WB, Wood IS. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 2008; 100:227–235.
  • Oltmanns KM GH, Rudolf S, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169:1231–1237.
  • Regazzetti C PP, Gremeaux T, et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 2009; 58:95–103.
  • Goossens GH BA, Venteclef N, Essers Y, Cleutjens JP, Konings E, Jocken JW, Cajlakovic M, Ribitsch V, Clément K, Blaak EE. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 2011; 124:67–76.
  • Hodson L HS, Karpe F, Frayn KN. Metabolic signatures of human adipose tissue hypoxia in obesity. Diabetes 2013; 62:1417–1425.
  • Aouad LJ TK, Waters KA. Effects of acute intermittent hypercapnic hypoxia on insulin sensitivity in piglets using euglycemic clamp. . Metabolism 2008; 57:1056–1063.
  • Engstrom G HB, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253:574–581.
  • Nakajima K KY, Muneyuki T, et al. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008; 134:712–718.
  • Yeh HC PN, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28:1472–1479.
  • Ford ES MD. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004; 27:2966–2970.
  • Feary JR RL, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65:956–962.
  • Bolton CE EM, Ionescu AA, et al. Insulin resistance and inflammation - A further systemic complication of COPD. COPD 2007; 4:121–126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.